These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 37163733)
1. Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype. Sung JH; Ou Y; Barger SW eNeuro; 2023 Apr; 10(4):. PubMed ID: 37163733 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632 [TBL] [Abstract][Full Text] [Related]
4. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice. Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217 [TBL] [Abstract][Full Text] [Related]
5. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
6. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology. Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060 [TBL] [Abstract][Full Text] [Related]
7. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429 [TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287 [TBL] [Abstract][Full Text] [Related]
9. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E ε4 modulates astrocyte neuronal support functions in the presence of amyloid-β. Fleeman RM; Kuhn MK; Chan DC; Proctor EA J Neurochem; 2023 May; 165(4):536-549. PubMed ID: 36762973 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146 [TBL] [Abstract][Full Text] [Related]
13. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. Keeney JT; Ibrahimi S; Zhao L J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005 [TBL] [Abstract][Full Text] [Related]
14. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669 [TBL] [Abstract][Full Text] [Related]
15. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668 [TBL] [Abstract][Full Text] [Related]
16. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy. Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease. Butterfield DA; Mattson MP Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033 [TBL] [Abstract][Full Text] [Related]
18. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680 [TBL] [Abstract][Full Text] [Related]
19. Obesity Accelerates Alzheimer-Related Pathology in Moser VA; Pike CJ eNeuro; 2017; 4(3):. PubMed ID: 28612048 [TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]